NM_005194.4:c.757G>A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005194.4(CEBPB):c.757G>A(p.Ala253Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000329 in 1,550,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005194.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEBPB | NM_005194.4 | c.757G>A | p.Ala253Thr | missense_variant | Exon 1 of 1 | ENST00000303004.5 | NP_005185.2 | |
CEBPB | NM_001285878.1 | c.688G>A | p.Ala230Thr | missense_variant | Exon 1 of 1 | NP_001272807.1 | ||
CEBPB | NM_001285879.1 | c.163G>A | p.Ala55Thr | missense_variant | Exon 1 of 1 | NP_001272808.1 | ||
CEBPB-AS1 | NR_125739.1 | n.280C>T | non_coding_transcript_exon_variant | Exon 1 of 7 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152062Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000260 AC: 4AN: 153972Hom.: 0 AF XY: 0.0000482 AC XY: 4AN XY: 83014
GnomAD4 exome AF: 0.0000107 AC: 15AN: 1398314Hom.: 0 Cov.: 33 AF XY: 0.0000101 AC XY: 7AN XY: 690876
GnomAD4 genome AF: 0.000237 AC: 36AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74412
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.757G>A (p.A253T) alteration is located in exon 1 (coding exon 1) of the CEBPB gene. This alteration results from a G to A substitution at nucleotide position 757, causing the alanine (A) at amino acid position 253 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at